Tingbo Liang
Impact in
- Hepatology top 0.5%
- Hepatocellular Carcinoma Treatment and Prognosis
- Cancer Research top 1%
Papers in
- Co-authors
- Xueli Bai (95 shared papers)Xing Huang (28 shared papers)Gang Zhang (20 shared papers)Tianyu Tang (21 shared papers)Xueli Bai (43 shared papers)Yinan Shen (21 shared papers)Xiaozhen Zhang (32 shared papers)Yu Lou (14 shared papers)
- Journals
- Cancer Letters (12 papers)Journal of Clinical Oncology (12 papers)Medicine (7 papers)Annals of Surgery (7 papers)Signal Transduction and Targeted Therapy (6 papers)
- Partner nations
- ChinaUnited StatesMadagascar
In The Last Decade
Tingbo Liang
293 papers receiving 8.1k citations
Tingbo Liang's Hit Papers
Peers
Comparison fields: 5 of 152
- Hepatology 1.1k
- Cancer Research 1.5k
- Oncology 2.6k
- Immunology 1.8k
- Molecular Biology 3.0k
Countries citing papers authored by Tingbo Liang
This map shows the geographic impact of Tingbo Liang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tingbo Liang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tingbo Liang more than expected).
Fields of papers citing papers by Tingbo Liang
This network shows the impact of papers produced by Tingbo Liang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tingbo Liang. The network helps show where Tingbo Liang may publish in the future.
Co-authors
The 25 scholars most cited alongside Tingbo Liang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 306 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Advantages of targeting the tumor immune microenvironment over blocking immune checkpoint in cancer immunotherapy Hit paper breakdown → | 2021 | 358 |
| 2 | 2020 | 338 | |
| 3 | The gluconeogenic enzyme PCK1 phosphorylates INSIG1/2 for lipogenesis Hit paper breakdown → | 2020 | 260 |
| 4 | 2017 | 237 | |
| 5 | Oncolytic virotherapy: basic principles, recent advances and future directions Hit paper breakdown → | 2023 | 213 |
| 6 | 2003 | 186 | |
| 7 | 2020 | 166 | |
| 8 | A non-canonical cGAS–STING–PERK pathway facilitates the translational program critical for senescence and organ fibrosis Hit paper breakdown → | 2022 | 163 |
| 9 | 2012 | 160 | |
| 10 | 2021 | 158 | |
| 11 | 2020 | 133 | |
| 12 | mRNA vaccines in disease prevention and treatment Hit paper breakdown → | 2023 | 131 |
| 13 | 2006 | 125 | |
| 14 | 2018 | 123 | |
| 15 | 2021 | 116 | |
| 16 | 2021 | 114 | |
| 17 | 2017 | 111 | |
| 18 | The gut microbiota reprograms intestinal lipid metabolism through long noncoding RNA Snhg9 Hit paper breakdown → | 2023 | 102 |
| 19 | 2019 | 100 | |
| 20 | 2017 | 99 |
About Tingbo Liang
Tingbo Liang is a scholar working on Oncology, Surgery, Molecular Biology, Hepatology and Epidemiology, having authored 306 papers that have together received 8.1k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (66 papers), Organ Transplantation Techniques and Outcomes (51 papers), Cancer Immunotherapy and Biomarkers (34 papers), Liver Disease and Transplantation (33 papers), Hepatocellular Carcinoma Treatment and Prognosis (30 papers), Liver Disease Diagnosis and Treatment (27 papers), Immune cells in cancer (21 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (17 papers). The work is most often cited by research in Hepatology (1.1k citations), Cancer Research (1.5k citations), Oncology (2.6k citations), Immunology (1.8k citations) and Molecular Biology (3.0k citations). Tingbo Liang has collaborated with scholars based in China, United States and Madagascar. Frequent co-authors include Xueli Bai, Xing Huang, Gang Zhang, Tianyu Tang, Xueli Bai, Yinan Shen, Xiaozhen Zhang, Yu Lou, Tao Ma and Shusen Zheng. Their work appears in journals such as Cancer Letters, Journal of Clinical Oncology, Medicine, Annals of Surgery and Signal Transduction and Targeted Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.